Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course preoperative radiotherapy plus chemotherapy for locally advanced rectal cancer
jRCTs051220171Phase 2Recruiting
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in rectal cancer. Primary endpoint: Pathological complete response rate. Started Mar 2023; status: recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs051220171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051220171.